The problem
The genomics revolution has not yet benefited veterinary medicine, leaving pathogenic diseases untreated and vaccines outdated.
The solution
Developing a portfolio of breakthrough vaccines and medicines for chronic animal diseases based on the latest advances in genome engineering and nucleic acid-based therapies.
Our engagement
Anterra incubated this company.